280. Huge arteriovenous malformation with cervicofacial or limb lesion
22 clinical trials,   26 drugs   (DrugBank: 13 drugs),   11 drug target genes,   147 drug target pathways

Searched query = "Huge arteriovenous malformation with cervicofacial or limb lesion", "Huge arteriovenous malformation", "Arteriovenous malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2019-003573-26-BE
(EUCTR)
18/12/2019Evaluating the safety and efficacy of Trametinib in Arterio-Venous Malformations that are refractory to standard careMonocentric pilot trial evaluating efficacy of Trametinib in Arteriovenous Malformations that are refractory to standard treatments or for which standard treatment are contra-indicated - TRAMAV Arteriovenous Malformations that are refractory to standard treatments or for which standard treatment are contra-indicated;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]Trade Name: Mekinist
Product Name: Mekinist
Cliniques universitaires Saint-LucNULLNAFemale: yes
Male: yes
20Phase 2Belgium